Implementation of a new technological line for expansion of the production capacity in Galen - N Ltd.

GALEN-N Ltd. started a production activity in 2001, producing mainly essential oils, dry natural extracts, resinoids and active pharmaceutical substances and substances. Today, the company is the largest Bulgarian manufacturer and exporter of these products. The expansion of market positions and the increase of the competitiveness of the foreign markets, characterized by high intensity of the competitive struggle, necessitate constant improvement of the production process in order to meet the current trends in the branch, the dynamics of the consumer demand development and the requirements towards the end products. In view of this, the implementation of this project is envisaged, with the main objective of improving the production capacity of the company by optimizing the production processes, increasing the competitiveness and increasing its export potential. The project is related to the expansion of the capacity of the existing business site and will be accomplished through the following activities eligible under this procedure: - Activity to improve production capacity (to be achieved through the purchase of a Technology Line for the production of dry extracts of dried vegetal mass, pretreated with primary processing by steam distillation - 1 pc.), leading to improvement of the production processes, production costs and improvement of the products offered. The project activity and expected results will contribute to effectively addressing the problems and constraints of the company's development and competitiveness, due to the lack of sufficient production capacity, the use of obsolete technologies and equipment and high production costs, as well as lower quality produced products. The project also falls under the priorities of this procedure, related to thematic and regional prioritization.

Comments
Leave a comment

Overview

Status Terminated (termination date)
Start date 22 Dec, 2020
End date 22 Dec, 2021
Contract date 22 Dec, 2020
View in UMIS

Beneficiary

Financial information

Total cost 1,071,000.00
Grant 749,700.00
Self finance 321,300.00
Total paid 0.00
EU participation percent 85.0%

Location